G Lakner

Effects of third generation aromatase inhibitors on bone health and other safety parameters: Results of an open, randomised, multi-centre study of letrozole, exemestane and anastrozole in healthy postmenopausal women

Eugène McCloskey, R.A. Hannon, G Lakner et al. · European Journal of Cancer · 2007 · 90 citations

Medicine, Endocrinology, Pharmacology +15

A pilot study of golexanolone, a new GABA-A receptor-modulating steroid antagonist, in patients with covert hepatic encephalopathy

Sara Montagnese, Mette Munk Lauridsen, Hendrik Vilstrup et al. · Journal of Hepatology · 2021 · 58 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

The letrozole (L), exemestane (E), and anastrozole (A) pharmacodynamics (LEAP) trial: A direct comparison of bone biochemical measurements between aromatase inhibitors (AIs) in healthy postmenopausal women

Eugène McCloskey, R.A. Hannon, G Lakner et al. · Journal of Clinical Oncology · 2006 · 28 citations

Medicine, Endocrinology, Pharmacology +17

High aortoiliac occlusion: treatment with thoracic aorta to femoral arterial bypass.

G Lakner, L Lukács · PubMed · 1984 · 13 citations

Medicine, Surgery, Cardiothoracic Surgery +5

Gas chromatography nitrogen phosphorous detection (GC-NPD) assay of tofisopam in human plasma for pharmacokinetic evaluation

Mária Tóth, Andrea Bereczki, Sándor Drabant et al. · Journal of Pharmaceutical and Biomedical Analysis · 2006 · 11 citations

Pharmacy, Pharmaceutical Analysis, Pharmacokinetics +5